Results 131 to 140 of about 26,469 (241)

Materials and System Design for Self‐Decision Bioelectronic Systems

open access: yesAdvanced Materials, Volume 38, Issue 9, 12 February 2026.
This review highlights how self‐decision bioelectronic systems integrate sensing, computation, and therapy into autonomous, closed‐loop platforms that continuously monitor and treat diseases, marking a major step toward intelligent, self‐regulating healthcare technologies.
Qiankun Zeng   +9 more
wiley   +1 more source

A Closed‐Loop‐Capable Neural Interface Platform for Deep Brain Modulation via Integrated Non‐Viral Gene Delivery, NIR Optogenetics, and Electrophysiological Recording

open access: yesAdvanced Science, Volume 13, Issue 7, 3 February 2026.
A multifunctional, 3D porous neural interface combines non‐viral gene delivery and NIR optogenetics to enable minimally invasive, closed‐loop modulation of deep‐brain circuits. Abstract Closed‐loop neuromodulation requires precise, stable, and cell‐specific control of neural circuits with minimal invasiveness.
Chao‐Yi Chu   +14 more
wiley   +1 more source

Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology

open access: yesAdvanced Science, Volume 13, Issue 7, 3 February 2026.
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang   +7 more
wiley   +1 more source

An ITPR1 Variant in the IP3‐ITPR1 Binding Pocket Associated With a Clinical Phenotype of Athetoid Cerebral Palsy

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 2, Page 459-467, February 2026.
ABSTRACT A de novo, missense variant in ITPR1‐inositol 1,4,5‐trisphosphate receptor type 1 (ITPR1), p.(Tyr567Cys), was identified by trio whole‐genome sequencing in an individual diagnosed with Spinocerebellar ataxia 29 (SCA29) who was affected by cerebral palsy and global developmental delay.
Thania Ordaz   +12 more
wiley   +1 more source

A double CYP27A1 gene mutation in spinal cerebrotendinous xanthomatosis in a patient presenting with spastic gait: a case report

open access: yesJournal of Medical Case Reports
Background Cerebrotendinous xanthomatosis (CTX, OMIM #213700) is a rare inherited metabolic disease caused by the mutation in the CYP27A1 gene. Spinal CTX is a rare clinical subgroup of CTX which lacks typical symptoms seen in classical CTX.
Je Hong Min   +3 more
doaj   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 2, February 2026.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov   +8 more
wiley   +1 more source

Pontine malformation, undecussated pyramidal tracts, and regional polymicrogyria: a new syndrome. [PDF]

open access: yesPediatr Neurol, 2014
Irahara K   +13 more
europepmc   +1 more source

Corticomotor Excitability Changes Induced by Progressive Balance Exercises in Chronic Ankle Instability: a Randomized Clinical Trial

open access: yesBrain and Behavior, Volume 16, Issue 2, February 2026.
Corticomotor excitability changes induced by progressive balance exercises in chronic ankle instability: A randomized clinical trial. ABSTRACT Background Progressive balance exercises may change corticomotor excitability during the learning process of postural stability control.
Mahdis Purzolfi   +2 more
wiley   +1 more source

Cortico-spinal reorganization in postanoxic conditions in children: a series of case reports [PDF]

open access: yesРМЖ. Мать и дитя
D.S. Kan'shina1, M.V. Ublinskiy1, I.A. Mel'nikov1, S.A. Valliulina1, T.A. Akhadov1, S.S. Nikitin2, V.P. Zykov3, E.E. Drozhevskaya4 1Research Institute of Emergency Pediatric Surgery and Traumatology, Moscow,   Russian Federation ...
D.S. Kan'shina   +7 more
doaj  

Comorbidities at MS Diagnosis and Their Association With Treatment Persistence: Real‐World Clinical Data

open access: yesBrain and Behavior, Volume 16, Issue 2, February 2026.
Comorbidity was present in approximately half of the patients with relapsing‐remitting multiple sclerosis in this Finnish cross‐sectional cohort. Comorbidities, especially psychiatric diseases, were associated with lower persistence on injectable disease‐modifying treatments.
Henrik Ahvenjärvi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy